. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Br J Haematol. 2014 Nov 10;168(6):845–853. doi: 10.1111/bjh.13219

Table II. Sensitivity and specificity of FDG-PET/CT and conventional imaging in diagnosing residual tumour by biopsy and predicting progressive disease or relapse.

	Sensitivity (%)	Specificity (%)	Positive predictive value (%)	Negative predictive value (%)
^*FDG-PET for positive biopsy	100	60	25	100
Conventional imaging for positive biopsy	100	20	14	100
^*FDG-PET for progressive disease or relapse	100	69	50	100
Conventional imaging for progressive disease or relapse	75	15	21	67

Abbreviations: FDG-PET/CT, ¹⁸F-labelled–fluorodeoxyglucose positron emission tomography with computerized tomography

Patient 9 had indeterminate findings on FDG-PET and was not included in this analysis.